← Leaderboards
Nahid J. Rianon
University Of Texas Hlth Sci Ctr Houston
$1,146,117
Attributed
$2,140,234
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $675.6K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,140,234 · 2
By mechanism
R01$1,988,234 · 1
R03$152,000 · 1
Top collaborators
- Miryoung Lee3 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Holger K. Eltzschig$19,015,874
- Frederick A Moore$6,785,208
- Mary Ifeoluwa Adeyeye$146,206
Others in their field
Top investigators on “Bone Turnover”
- Isidro B. Benjamin Salusky · University Of California Los Angeles$16,312,111
- Susan L Greenspan · Beth Israel Deaconess Medical Center$16,055,047
- Sundeep Khosla · Mayo Clinic Rochester$15,771,740
- Elizabeth J. Shane · Mayo Clinic Rochester$15,303,412
- Clifford J Rosen · Icahn School Of Medicine At Mount Sinai$14,663,738
- Jay Steven Magaziner · University Of Maryland Baltimore$14,528,666
Research focus
Bone TurnoverCohortOsteoporosisDiabetes MellitusBone DensityMonitorFractureNeckPathway InteractionsSkeletalBone LossReportingParticipantBonePreventionElderlyAgingEpidemiologyDifferential ExpressionAccelerationDual-Energy X-Ray AbsorptiometryFemaleBone HealthCounty
Grant awards (5)
Genomic, transcriptomic, and metabolic effects on skeletal health in Mexican Americans$649,676
R01 · FY2025 · AG
Genomic, transcriptomic, and metabolic effects on skeletal health in Mexican Americans$662,934
R01 · FY2024 · AG
Genomic, transcriptomic, and metabolic effects on skeletal health in Mexican Americans$675,624
R01 · FY2023 · AG
Effects of ACE Inhibitor (ACEI) use on bone turnover in humans: a clinical trial$76,000
R03 · FY2014 · AG · contact PI
Effects of ACE Inhibitor (ACEI) use on bone turnover in humans: a clinical trial$76,000
R03 · FY2013 · AG · contact PI